Head-to-head · Cost-Efficiency Index
Aquivia Health vs RNK Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Aquivia Health
Shoppers who want clinician-reviewed compounded GLP-1s with the option to move up to brand-name Ozempic or Zepbound.
Visit Aquivia HealthRNK Health
Shoppers who want one all-in monthly price for a compounded GLP-1 and are fine confirming the exact price for their dose at checkout.
Visit RNK HealthThe verdict
Aquivia Health takes it, leading the Cost-Efficiency Index 62 to 59. Aquivia Health is a clinician-led, self-pay telehealth platform offering compounded GLP-1 therapy with the option to step up to branded Ozempic or Zepbound. RNK Health still earns a C — Shoppers who want one all-in monthly price for a compounded GLP-1 and are fine confirming the exact price for their dose at checkout.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Aquivia Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Aquivia Health | RNK Health |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 59/100 |
| Semaglutide / mo | $149/mo | From $197/moCompounded, month to month |
| Tirzepatide / mo | $179/mo | From $297/moCompounded, month to month |
| Semaglutide / yr (modeled) | $1,788 | $2,364 |
| Tirzepatide / yr (modeled) | $2,148 | $3,564 |
| Coverage | Coverage not published | Not published (US only) |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #264 | #269 |
Aquivia Health
62/100Where the value is
- Clinical care provided by Open Loop Healthcare Partners, PC — a reused, verified MSO network
- Named leadership: Steven Bishop MD (CMO), Phillip Gray PharmD (Chief Pharmacist), Tom Foster (President)
- Itemized public pricing: compounded semaglutide $149/mo, tirzepatide $179/mo, Ozempic $1,299, Zepbound $1,399
The tradeoffs
- No public list of states served — you must complete intake to learn if your state qualifies
- No named 503A compounding pharmacy partner, limiting licensure verification
RNK Health
59/100Where the value is
- One monthly price covers the medication, the physician consultation and prescription, syringes and wipes, and shipping, with no separate membership or visit fee
- Month to month: you can cancel, pause or skip from your account, and it emails the upcoming amount 7 days before each renewal
- Both compounded semaglutide and tirzepatide, with NAD+, sermorelin, B12 and naltrexone available on the same account
The tradeoffs
- Both prices are "from" figures and the pages don't say what a higher dose costs, so confirm the price for your dose at checkout
- Fees are non-refundable once you submit the intake, unless a provider finds you ineligible or the medication arrives damaged or wrong
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.